Insulin treatment post myocardial infarction: The DIGAMI study

Advances in Experimental Medicine and Biology

Volumn 498, Issue , 2001, Pages 279-284

  Malmberg, Klas ^a   Norhammar, Anna ^a   Rydén, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MORTALITY; OCCLUSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; VASCULAR DISEASE;

EID: 0035699072     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1321-6_35     Document Type: Conference Paper

References (14)

1. Myocardial infarction in patients with diabetes mellitus
2. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
3. A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: Effects on one year mortality
4. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
5. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus
6. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis
7. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus
8. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients
9. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy
10. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. An overview of randomized placebo controlled trials
11. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial
12. Glucose-insulin-potassium in acute myocardial infarction. The time has come for a large, prospective trial
13. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control
14. Thromboxane biosynthesis and platelet function in type 2 diabetes mellitus